Hindmarsh will be responsible for the design and construction of a combination of highly complex laboratories/research areas including PC2 Laboratory requirements, along with certifications for Goods Manufacturing Practice (GMP), Therapeutic Goods Administration (TGA) and Office of the Gene Technology Regulator (OGTR).
The works include design management with Subcontractor early engagement for the installation of complex services and infrastructure/plant to service the process engineering equipment required within the facility to produce RNA-based products for clinical trials; Construction of new two storey concrete/steelwork structure;
Installation of cleanroom paneling and interlocking system to ensure air leakage requirements and pressure differentials are achieved, and Installation of new substation and generator to achieve redundancy requirements.